Fred Alger Management’s Adaptimmune Therapeutics ADAP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-25,000
| Closed | -$297K | – | 535 |
|
|
2018
Q2 | $297K | Buy |
+25,000
| New | +$297K | ﹤0.01% | 379 |
|
|
2016
Q2 | – | Sell |
-23,045
| Closed | -$187K | – | 523 |
|
|
2016
Q1 | $187K | Sell |
23,045
-35,150
| -60% | -$285K | ﹤0.01% | 445 |
|
|
2015
Q4 | $702K | Buy |
58,195
+16,650
| +40% | +$201K | ﹤0.01% | 414 |
|
|
2015
Q3 | $497K | Buy |
41,545
+13,100
| +46% | +$157K | ﹤0.01% | 435 |
|
|
2015
Q2 | $521K | Buy |
+28,445
| New | +$521K | ﹤0.01% | 465 |
|